back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-05-04 Tx date 2018-05-03 |
$COT
Cotinga Pharmaceuticals Inc. (formerly, Critical Outcome Technologies Inc.) |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+13,200 vol |
17,600 | |
| Filed 2018-05-04 Tx date 2018-05-03 |
$COT
Cotinga Pharmaceuticals Inc. (formerly, Critical Outcome Technologies Inc.) |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$5,016
+13,200 vol $0.38 each |
23,570 | |
| Filed 2017-12-28 Tx date 2017-12-20 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+78,570 vol |
126,534 | |
| Filed 2017-09-23 Tx date 2015-10-15 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-23 Tx date 2017-09-19 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$5,104
+4,400 vol $1.16 each |
10,370 | |
| Filed 2017-09-23 Tx date 2017-09-19 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+4,400 vol |
4,400 | |
| Filed 2017-07-01 Tx date 2017-06-30 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-431,684 vol |
||
| Filed 2017-07-01 Tx date 2017-06-30 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-431,685 vol |
47,964 | |
| Filed 2017-07-01 Tx date 2017-06-30 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-431,684 vol |
||
| Filed 2017-06-30 Tx date 2017-06-30 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Holder: Dr. John Yoo Medicine Professional Corp. (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-22,500 vol |
2,500 | |
| Filed 2017-06-30 Tx date 2017-06-30 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-431,684 vol |
47,965 | |
| Filed 2017-06-30 Tx date 2017-06-30 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-53,730 vol |
5,970 | |
| Filed 2017-06-30 Tx date 2017-06-30 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Holder: Spouse (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-53,550 vol |
5,950 | |
| Filed 2016-10-17 Tx date 2016-10-13 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+183,950 vol |
479,649 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,715
+19,700 vol $0.75 each |
||
| Filed 2016-06-20 Tx date 2016-06-17 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Holder: Spouse (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,375
+44,500 vol $0.75 each |
||
| Filed 2016-06-20 Tx date 2016-06-17 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Holder: Spouse (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,375
+44,500 vol $0.75 each |
||
| Filed 2016-06-20 Tx date 2016-06-17 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Holder: Spouse (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,375
+44,500 vol $0.75 each |
59,500 | |
| Filed 2016-06-20 Tx date 2016-06-17 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,715
+19,700 vol $0.75 each |
||
| Filed 2016-06-20 Tx date 2016-06-17 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,715
+19,700 vol $0.75 each |
59,700 | |
| Filed 2016-04-04 Tx date 2016-04-04 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Holder: Dr. John Yoo Medicine Professional Corp. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,600
+40,000 vol $0.49 each |
||
| Filed 2016-04-04 Tx date 2016-04-04 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,600
+40,000 vol $0.49 each |
40,000 | |
| Filed 2016-04-04 Tx date 2016-04-04 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,600
+40,000 vol $0.49 each |
||
| Filed 2016-04-04 Tx date 2016-04-04 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,600
+40,000 vol $0.49 each |
||
| Filed 2016-04-04 Tx date 2015-10-15 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-04 Tx date 2016-04-04 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Holder: Spouse (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,350
+15,000 vol $0.49 each |
15,000 | |
| Filed 2016-04-04 Tx date 2015-10-15 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Holder: Spouse (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-04 Tx date 2016-04-04 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Holder: Dr. John Yoo Medicine Professional Corp. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,600
+40,000 vol $0.49 each |
||
| Filed 2016-01-08 Tx date 2016-01-08 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+147,850 vol |
295,699 | |
| Filed 2015-10-19 Tx date 2015-10-15 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Holder: Dr. John Yoo Medicine Professional Corp. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
| Filed 2015-10-19 Tx date 2015-10-15 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-19 Tx date 2015-10-15 |
$COT
Critical Outcome Technologies Inc. |
Yoo, Heung-Joon (John)
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+147,849 vol |
147,849 |